Skip to main content

Jeffrey A. Cohen, MD, Describes His Comparison of Alemtuzumab and Interferon Beta-1a in Patients With Multiple Sclerosis

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Jeffrey A. Cohen, MD, Describes His Comparison of Alemtuzumab and Interferon Beta-1a in Patients With Multiple Sclerosis

User login

Username

Password

Reset your password

Type	Lead	score